This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Yunneng Tang: Innovator in Cancer Vaccine Research
Introduction
Yunneng Tang is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of cancer research, particularly in the development of innovative cancer vaccine compositions. His work aims to enhance the prevention and treatment of cancer, showcasing his dedication to advancing medical science.
Latest Patents
Yunneng Tang holds a patent for "Cancer vaccine compositions and methods for using same to prevent and/or treat cancer." This invention is based on cancer vaccine compositions that comprise PTEN- and p53-deficient cancer cells with an activated TGFβ-Smad/p63 signaling pathway. The methods outlined in this patent are designed to prevent and treat cancer effectively.
Career Highlights
Yunneng Tang is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to work on groundbreaking research in cancer treatment. His expertise and innovative approach have positioned him as a key figure in the fight against cancer.
Collaborations
Yunneng Tang collaborates with esteemed colleagues, including Jean Zhao and Xin Cheng. Their combined efforts contribute to the advancement of cancer research and the development of effective treatment strategies.
Conclusion
Yunneng Tang's work in cancer vaccine research exemplifies the impact of innovation in medicine. His contributions are vital in the ongoing battle against cancer, and his patent reflects a promising avenue for future treatments.